Tomboy,
I hope your calculations are correct.
I am more optimistic regarding the 4c for the 3rd quarter.
With regard to cardiocel revenue I hope you took into account the fact that, as far as I can ascertain, they are selling to many centres on 90 day terms. Accordingly the current quarterly will still be reflecting income from months BEFORE the Malaga facility began production.
So the 4c end of this month will certainly show increasing revenue but the following one will, in my opinion be the eye opener.
Fox
Bio-Implants, page-32
-
- There are more pages in this discussion • 17 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$12.49 |
Change
0.490(4.08%) |
Mkt cap ! $264.0M | |||
| Open | High | Low | Value | Volume |
| $12.11 | $12.49 | $11.50 | $155.8K | 13.16K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 175 | $11.81 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $12.49 | 77 | 1 |
View Market Depth
| Last trade - 16.10pm 27/09/2024 (20 minute delay) ? |
| AVR (ASX) Chart |